Results

Total Results: 2,266 records

Showing results for "determining".

81. Cad-Pci-Bypass Surveillance (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
    May 01, 2013 - Findings and Conclusions ........................................................................ 2 2.6 Determining … withdrawal of a drug or surgical device from the market, a black box warning from FDA, etc. 2.6 Determining

82. Assessing Applicability (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
    January 01, 2009 - Consider applicability when determining the scope of the review or when identifying key questions to … Determining how well the study population approximates the target population is critical to determining … surgical repair and other therapies, the setting where the studies take place is very important in determining

83. Assessing Applicability (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/assessing-applicability.ppt
    January 01, 2009 - Consider applicability when determining the scope of the review or when identifying key questions to … Determining how well the study population approximates the target population is critical to determining … surgical repair and other therapies, the setting where the studies take place is very important in determining

84. PowerPoint Presentation (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
    June 01, 2012 - It is essential in determining the future risk of developing a disease and for assessing clinical utility … Penetrance is a key factor in determining the future risk of developing disease and assessing the overall … In such cases, determining the overall clinical utility of a genetic test is difficult. … Other Challenges (Continued) Difficulties can arise when determining susceptibility or risk in asymptomatic … It shows the importance of accurately determining family history.

85. PowerPoint Presentation (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
    June 01, 2012 - It is essential in determining the future risk of developing a disease and for assessing clinical utility … Penetrance is a key factor in determining the future risk of developing disease and assessing the overall … In such cases, determining the overall clinical utility of a genetic test is difficult. … Other Challenges (Continued) Difficulties can arise when determining susceptibility or risk in asymptomatic … It shows the importance of accurately determining family history.

86. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
    March 01, 2012 - In a CER, we are charged with determining the balance of benefits and harms, strength of the evidence … CERs are precluded from using cost as a factor in determining comparative effectiveness. … AHRQ should strive to be consistent in its criteria for determining which therapies are included in … determining the applicability of evidence. … determining the applicability of evidence.

87. Maternal and Child Outcomes Associated With the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/outcomes-nutrition/research
    October 01, 2022 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

88. Executive Summary: Breastfeeding and Health Outcomes for Infants and Children (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-research-executive-summ.pdf
    March 01, 2025 - We used established methods for determining the potential risks of bias and certainty of our findings

89. Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/effect-dietary-digestible/research
    March 01, 2025 - Synthesis of such evidence is important for determining the Dietary Reference Intakes (DRI) for carbohydrates

90. Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
    September 06, 2023 - Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) Evidence-based Practice Center Technical Brief Protocol Project Title: Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) I. Background and Objectives for the Technical…

91. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/selecting-evidence.ppt
    January 01, 2010 - Determining suitability should consider the natural history of the disease or exposure and the potential … Determining whether or not a hypothesis is being tested or generated is an important consideration in

92. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/selecting-evidence.ppt
    January 01, 2010 - Determining suitability should consider the natural history of the disease or exposure and the potential … Determining whether or not a hypothesis is being tested or generated is an important consideration in

93. An Ethical Framework for N-of-1 Trials: Clinical Care, Quality Improvement, or Human Subjects Research? (Chapter 2) | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/n-1-trials/research-2014-3
    August 01, 2019 - investigators, and institutional research ethics boards determine the most appropriate approach in determining … “The research-treatment distinction: A problematic approach for determining which activities should have

94. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/disruptive-behavior/research
    April 01, 2025 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

95. Topic 0586 LUTS Secondary to BPH NSD FINAL (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0713-140625.pdf
    January 07, 2014 - Topic 0586 LUTS Secondary to BPH NSD FINAL Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia Nomination Summary Document Results of Topic S…

96. What is the comparative effectiveness of genetic and other diagnostic tests to identify and treat intellectual and developmental disabilities caused by genetic mutations in post-natal to early childhood populations? | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-genetic-and-other-diagnostic-tests-to-identify-and-treat-intellectual-and-developmental-disabilities-caused-by-genetic-mutations-in-post-natal-to-early-childhood-populations
    November 01, 2017 - Determining this would address uncertainty policymakers and clinicians feel regarding the utility of

97. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
    December 01, 2017 - events (including asthma worsening and respiratory tract infections during the treatment period) when determining

98. The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment Endpoints (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda-johnson.pdf
    August 27, 2012 - concern about patient involvement in protocol development  “When asking the public to assist in determining

99. PICO #1 Population(s): Children with infantile hemangiomas (IHs) Intervention(s): Early referral Comparator(s): Delayed referral Outcomes(s): Minimization of functional impairment and/or cosmetic deformity PICO #2 Population(s): Children… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/pico-1-populations-children-with-infantile-hemangiomas-ihs-interventions-early-referral-comparators-delayed-referral-outcomess-minimization-of-functional-impairment-andor-cosmetic-deformity-pico-2-populations-children-with
    November 01, 2017 - There is currently no algorithm to aid clinicians in determining which IH lesions require specialist

100. Imaging for Pretreatment Staging of Small Cell Lung Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/lung-cancer-staging/research-protocol
     December 01, 2019 - Staging Staging involves determining the extent of disease and informs the choice of treatment. … the inclusion criteria to include single-modality studies with an appropriate reference standard for determining … have enrolled slightly different types of patients or used slightly different reference standards for determining … We will also consider the funding sources of the studies in determining the risk of reporting bias. … Were the people determining the reference standard unaware of the diagnostic test results?